Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 19, 2019
HTG Molecular Diagnostics announced the release of its HTG EdgeSeq Reveal data analysis software, version 2.0.0.
read more
Friday, December 29, 2017
HTG Molecular Diagnostics announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany.
read more
Thursday, August 13, 2020
HTG Molecular Diagnostics announced the signing of a Commercialization and Distribution Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN.
read more
HTG Molecular Diagnostics announced the signing of three new European distributor agreements to promote HTG products and services in Nordic and Eastern European Countries with Denmark, Czech Republic, and Bulgaria.
read more
Tuesday, February 04, 2025
HealthTech BioActives (HTBA) announced the completion of a €25 million investment project to modernize its research, development and manufacturing center in Murcia, Spain.
read more
Monday, November 24, 2025
HRV Global Life Sciences announced a multi-year Contract Development & Manufacturing (CDMO) partnership with MetroChem API Pvt. Ltd. which will focus on the exclusive and semi-exclusive development, scale-up, and GMP manufacturing of multiple high-...
read more
Thursday, August 15, 2013
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a ...
read more
MARLBOROUGH, MASSACHUSETTS, USA — March 12, 2012 — A new white paper detailing how a flexible bioprocessing platform meets the changing needs of biomanufacturing is now available for download from Xcellerex, Inc., at http://www.xcellerex.com/...
read more
Hovione has announced the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
read more
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more
Wednesday, March 07, 2018
Hovione has concluded the sale of all of the share capital of iMAX Diagnostic Imaging.
read more
Hovione reported recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey, with the aim to increase capacity in existing technologies
read more
Hovione announced it has signed an agreement with Dragonfly Technologies, Inc. to gain access to its micellar technology for chemistry-in-water processes, developed by Prof. Bruce Lipshutz of the University of California, Santa Barbara (UCSB).
read more
Hovione has announced the opening of its new sales and customer support office in Osaka, Japan.
read more
Tuesday, January 29, 2019
Hovione has issued a bond of $50 million US dollars maturing in 2033.
read more